The Top European Biotech Funding Rounds in June
While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing…
While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing…
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and…
An emerging new electrophysiology technology, known as high-density microelectrode arrays, enables researchers to study in…
Russia has established itself as a hub for neurotech startups, attracting scientists and business people…
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
In spite of recent failures of clinical trials from others in the field, Swiss company…
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which…
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will…
British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US…
Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of…